2nd annual

Meetings and Events

Second Annual Conference, Bangkok, Thailand
May 16-18, 2007

[Note: All presentations are in .pdf format. You will need Adobe Reader to view.]

Presentation Title	Presenter
State of the Network	Jimmy Whitworth
Updates on Influenza Epidemiology in Thailand	Tawee Chotpitayasunondh
Updates on Influenza Epidemiology in Vietnam	Nguyen Duc Hien
Updates on Influenza Epidemiology in Indonesia	Santoso Soeroso
Network Structure and Introduction of the Network Training Plan	Jeremy Farrar
Network Coordinating Center (NCC) Update	Elaine Stockwell
Update on SEA-001 High vs. Standard Dose Oseltamivir in Influenza	John Beigel
Update on SEA-002 Pharmacologic Study of Oseltamivir in Healthy Volunteers	Yupaporn Wattanagoon
Update on SEA-003 Pharmcokinetic Study of Oseltamivir and Intravenous Zanamivir	Sasithorn Pukritayakamee
Update on SEA-004 Long Term Prophylaxis	Tawee Chotpitayasunondh
Report from the 2nd WHO Consultation on Clinical Aspects of Human Infections with H5N1 Virus	Tawee Chotpitayasunondh
Intensive Care Unit (ICU) Management	Jean-Daniel Chiche
AI Case Management in Thailand	Sorasak Lohchindarat
AI Case Management in Indonesia	Tjandra Y. Aditama
Animal Models and Preclinical Testing on Novel Therapeutic Agents	Albert Osterhaus
Overview of DSMB	Mario Chen
AE/SAE Reporting within the Network	Kelly Cahill
Emergency Unblinding within the Network	Bob Taylor
Laboratory Quality and ISO 15189 Certification	Janet Robinson
Assaying Anti-Influenza Drugs	Niklas Lindegardh
Clinical Monitoring Reports - What to Expect	Susan Vogel
Network Responses to Monitoring Reports	Christian Yoder
Viral Drug Resistance	Menno de Jong
The Antigenic and Genetic Evolution of Influenza Viruses	Derek J. Smith
Investigator Responsibilities and the 1572 Form	Julie Welch
Investigator Responsibilities to the DSMB	Mario Chen
Audits and FDA Warnings	Kelly Cahill
Data Discrepancy Forms	Patrick Murphy
Oseltamivir Adverse Events	John Beigel
Protocol Team Overview	Joseph Chiu
The Protocol Development Process in the Network	Bob Taylor
IND Regulations	John Tierney
Clinical Trial Design - What to Consider when Designing a Study	Kevin Baird